RAND Corporation started the clinical trial on shrinking the size of the Tobacco Power Wall to reduce adolescent tobacco use

Photo by Sara Kurfeß

The company RAND is conducting the clinical trial Shrinking the Size of the Tobacco Power Wall and Restricting the Number of Tobacco Products Displayed to Reduce Adolescent Tobacco Use.

The overall aim of this research is to experimentally evaluate the extent to which reducing the size of the tobacco power wall and the number of tobacco product units displayed influences tobacco use risk in adolescents.

It is planned to include 900 participants.

Actual study start date is October 30, 2020. The researchers expect to complete the study by May 31, 2023

Tobacco use intentions are the primary outcome measure.
The intentions to use tobacco, as assessed by a three item scales with type of tobacco product inserted in brackets:
1) Do you think you will try (tobacco product) soon?
2) Do you think you will try (tobacco product) in the next year?
3) If one of your best friends offered you (tobacco product) would you use it?

RAND Corporation ("research and development") is an American nonprofit global policy think tank created in 1948 by Douglas Aircraft Company to offer research and analysis to the United States Armed Forces. It is financed by the U.S. government and private endowment, corporations, universities and private individuals. The company has grown to assist other governments, international organizations, private companies and foundations with a host of defense and non-defense issues, including healthcare. RAND aims for interdisciplinary and quantitative problem solving by translating theoretical concepts from formal economics and the physical sciences into novel applications in other areas, using applied science and operations research.

The location of the study is as follows (further details can be found here https://ichgcp.net/clinical-trials-registry/NCT04632030) RAND, Pittsburgh, Pennsylvania, United States, 15213